The addition of methyl groups to TGFBI in CD4+ T cells derived from MS patients (Graves et al., 2014) might prevent autoimmune reactivity favoring Ca2+-calcineurin signaling and T cell activation (Graca, 2007). Here, CD4 is linked to myeloid sarcoma.